Forum Private Client Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
4,133
-79
-2% -$7.05K 0.13% 58
2026
Q1
$302K Sell
4,212
-43
-1% -$3.31K 0.1% 65
2025
Q4
$338K Sell
4,255
-295
-6% -$23.3K 0.12% 61
2025
Q3
$343K Buy
4,550
+5
+0.1% +$343 0.12% 60
2025
Q2
$314K Sell
4,545
-125
-3% -$8.2K 0.12% 63
2025
Q1
$316K Buy
4,670
+44
+1% +$2.63K 0.14% 59
2024
Q4
$208K Buy
4,626
+24
+0.5% +$1.35K 0.09% 75
2024
Q3
$289K Buy
4,602
+188
+4% +$11K 0.13% 63
2024
Q2
$261K Buy
4,414
+61
+1% +$3.82K 0.12% 64
2024
Q1
$347K Buy
4,353
+48
+1% +$3.67K 0.17% 57
2023
Q4
$340K Buy
+4,305
New +$306K 0.18% 54
2023
Q3
Sell
-4,172
Closed -$288K 10
2023
Q2
$288K Sell
4,172
-24
-0.6% -$1.71K 0.17% 59
2023
Q1
$312K Sell
4,196
-4
-0.1% -$335 0.2% 57
2022
Q4
$391K Sell
4,200
-3
-0.1% -$289 0.27% 47
2022
Q3
$401K Buy
4,203
+10
+0.2% +$990 0.3% 45
2022
Q2
$388K Buy
4,193
+7
+0.2% +$683 0.28% 47
2022
Q1
$424K Buy
+4,186
New +$440K 0.33% 46

Other funds holding CVS

Forum Private Client Group's CVS Position: Q2 2026 in Review

Forum Private Client Group reduced its CVS Health (CVS) stake by 1.9% in Q2 2026, selling an estimated $7.05K and leaving 4,133 shares worth $428K. The position accounts for 0.13% of the portfolio, ranked #58.

Forum Private Client Group first reported a position in CVS in Q1 2022 and has held it in 17 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Forum Private Client Group held 4,133 shares of CVS Health worth $428K as of Q2 2026.
  • Forum Private Client Group sold 79 CVS Health shares in Q2 2026, an estimated $7.05K.
  • CVS Health made up 0.13% of Forum Private Client Group's portfolio in Q2 2026, its #58 holding.
  • Forum Private Client Group first reported a position in CVS Health in Q1 2022 and has held it in 17 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Forum Private Client Group's 13F filing for Q2 2026, filed 12 Aug 2026.